Condensed Consolidated Statements Of Cash Flows (USD $) In Thousands	3 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Cash flows from operating activities:
Net income	$ 4,418	$ 3,346
Adjustments to reconcile net income to net cash provided by operating activities:
Benefit from deferred income taxes	(113)	(135)
Share-based compensation	1,443	1,279
Depreciation and amortization	265	205
Net realized losses on investments	151	6
Equity in net loss/(income) from limited liability company	74	(31)
Amortization of bond premiums	10	10
Excess income tax benefit from share-based compensation	(1,314)	(31)
Income tax benefit from dividends paid on unvested shares	(30)	(25)
(Increase)/decrease in operating assets:
Accounts receivable	1,303	(1,025)
Prepaid and other current assets	(2,131)	(70)
Increase/(decrease) in operating liabilities:
Accounts payable and accrued liabilities	248	(30)
Accrued compensation and benefits	2,948	2,598
Income taxes payable	695	24
Deferred rent	(41)	(30)
Net cash provided by operating activities	7,926	6,091
Cash flows from investing activities:
Investments in Company-sponsored products and other investments, net	(14)	(2,012)
Capital expenditures	(147)	(133)
Security deposits	(1)	286
Net cash used in investing activities	(162)	(1,859)
Cash flows from financing activities:
Cash dividends on common stock	(1,404)	(1,141)
Repurchase of common shares, net	(1,588)	(338)
Excess income tax benefit from share-based compensation	1,314	31
Income tax benefit from dividends paid on unvested shares	30	25
Proceeds from stock option exercises	71
Net gain on sale of shares for employee withholding		3
Net cash used in financing activities	(1,577)	(1,420)
Net increase in cash and cash equivalents during period	6,187	2,812
Cash and cash equivalents at beginning of period	29,128	36,447
Cash and cash equivalents at end of period	35,315	39,259
Supplemental disclosure of cash flow information:
Cash paid for income taxes	4,942	2,875
Supplemental disclosures of non-cash investing activities:
Net change in unrealized gains on available-for-sale securities, net of tax	$ (330)	$ 251